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Background
For many countries including Russia the development of
preventive HIV vaccine became one of the crucial prob-
lems in the national survivorship. The purpose of the
present study was to use phage display reverse panning
(RP) technique for obtaining HIV-1 envelop proteins for
LC-MS analysis of their major variability.
Methods
The naïve human ScFv antibody library expressed on the
M13 surface was created using total RNA from lym-
phocytes of 20 HIV-1 subtype A infected Russian patients.
Standard RT with random hexanucleotide oligos, cDNA
matrix heavy and light repertoires PCR-amplification,
ScFv genes PCR assembly and pCANTAB5E phagemid
cloning were used. HIV-1-specific human ScFv libraries
were selected after three rounds of biopanning with
recombinant diagnostic and native HIV-1 peptides, HIV
specificity was confirmed with ELISA and WB, recom-
binant phages were scanned with SPM contact mode
(NanoWizard, JPK instruments). Ultrafiltration, ultracen-
trifugation, HIV-1-specific libraries immobilized on
supermacroporous epoxy-activated cryogel RP (Protista
Biotechnology) and SDS-PAGE, consequently, were used
for viral proteins concentration. One-dimensional LC-
MS-MS Esquire6000Plus (Bruker Daltonics) tryptic cleav-
age virus peptide's identification was analyzed with Scaf-
fold (UK) and PEAKS (Canada) software complexes and
NCBI database.
Results
64 ScFv phage clones were analyzed in crisscross ELISA
tests for HIV specificity. ScFv libraries enriched on diag-
nostic recombinant HIV peptides gp110 and gp160 pro-
vided higher (≥96 percent, p ≤ 0.003) specificity to native
HIV proteins from patients isolates than libraries after
panning at laboratory U455 proteins. Therefore gp110-
gp160 phage-presented ScFv were immobilized at cryogel
column and concentrated native HIV-1 subtype A proteins
in RP successfully. Recombinant M13 has symmetric ScFv
''head'' structure at SPM images. Gp120 and gp41 pep-
tide's LC-MS-MS identification was possible only in sam-
ples run through all concentration stages including
reverse panning and was not possible in samples without
RP. Best RP column eluate fractions were detected in WB.
PEAKS complex can be used for HIV envelop peptides
quantitative and variability analysis, Scaffold's potency is
modest for it. Proteomics databases search revealed the
predominance of HIV-1 subtype A Env, Pol and Gag tryp-
tic peptides in native viral samples. The amount of the
particular HIV-1 protein variant in the LC-MS sample cor-
related with the probability of its detection by this
method.
Conclusion
RP concentration approach can be used for envelop varia-
tion's sequence identification of predominating native
HIV-1 quasispecies, circulating in the bloodstream. We
suppose RP technique and LC--MS-MS as crucial identifi-
cation methods for HIV preventive vaccines creation.
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